Parkinson’s treatment success

Israel’s Pharma Two B (see here in 2015) has successfully completed the Phase 3 human trial of its P2B001 treatment for Parkinson’s Disease. The trial met its primary and key secondary endpoints, and the company can now prepare for US FDA approval.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.